TheraRadar
← Back
Data updated: Mar 29, 2026

P AND L

Infectious DiseaseCardiovascularGastroenterology
Generics

P AND L is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology.

1993
Since
17
Drugs
-
Trials
107
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Gastroenterology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...